{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T14:40:05Z","timestamp":1734273605644,"version":"3.30.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,15]]},"DOI":"10.7759\/cureus.75737","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T14:06:28Z","timestamp":1734271588000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Biochemical and Lipid Profile Markers at Different Stages of Lung Cancer: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Rajyalakshmi","family":"Gogineni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natrajan","family":"Muninathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuppusamy","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra KC","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021, 25:45-52. 10.5114\/wo.2021.103829","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen Z","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014, 14:535-46. 10.1038\/nrc3775","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2217\/17520363.2.6.577","article-title":"Biomarkers in lung cancer: from early detection to novel therapeutics and decision making","volume":"2","author":"Scott A","year":"2008","unstructured":"Scott A, Salgia R. Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med. 2008, 2:577-86. 10.2217\/17520363.2.6.577","journal-title":"Biomark Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.929572","article-title":"The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment","volume":"13","author":"Aguilar-Cazares D","year":"2022","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Marroquin-Muci\u00f1o M, et al.. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. Front Endocrinol (Lausanne). 2022, 13:929572. 10.3389\/fendo.2022.929572","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007310","article-title":"Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer","volume":"11","author":"Naqash AR","year":"2023","unstructured":"Naqash AR, McCallen JD, Mi E, et al.. Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer. 2023, 11:e007310. 10.1136\/jitc-2023-007310","journal-title":"J Immunother Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.644303","article-title":"From good to bad: the opposing effects of PTHrP on tumor growth, dormancy, and metastasis throughout cancer progression","volume":"11","author":"Edwards CM","year":"2021","unstructured":"Edwards CM, Johnson RW. From good to bad: the opposing effects of PTHrP on tumor growth, dormancy, and metastasis throughout cancer progression. Front Oncol. 2021, 11:644303. 10.3389\/fonc.2021.644303","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez LP","year":"2020","unstructured":"Fern\u00e1ndez LP, G\u00f3mez de Cedr\u00f3n M, Ram\u00edrez de Molina A. Alterations of lipid metabolism in cancer: implications in prognosis and treatment. Front Oncol. 2020, 10:577420. 10.3389\/fonc.2020.577420","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu S","year":"2024","unstructured":"Liu S, Zhang X, Wang W, et al.. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024, 23:261. 10.1186\/s12943-024-02165-x","journal-title":"Mol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101754","article-title":"Painless capillary blood collection: a rapid evaluation of the onflow device","volume":"13","author":"Noble LD","year":"2023","unstructured":"Noble LD, Dixon C, Moran A, et al.. Painless capillary blood collection: a rapid evaluation of the onflow device. Diagnostics (Basel). 2023, 13:1754. 10.3390\/diagnostics13101754","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1533947","article-title":"Interleukin-6 measured using the automated electrochemiluminescence immunoassay method for the identification of intra-amniotic inflammation in preterm prelabor rupture of membranes","volume":"33","author":"Musilova I","year":"2020","unstructured":"Musilova I, Andrys C, Holeckova M, et al.. Interleukin-6 measured using the automated electrochemiluminescence immunoassay method for the identification of intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2020, 33:1919-26. 10.1080\/14767058.2018.1533947","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-6-5","article-title":"A high sensitivity assay for the inflammatory marker C-reactive protein employing acoustic biosensing","volume":"6","author":"McBride JD","year":"2008","unstructured":"McBride JD, Cooper MA. A high sensitivity assay for the inflammatory marker C-reactive protein employing acoustic biosensing. J Nanobiotechnology. 2008, 6:5. 10.1186\/1477-3155-6-5","journal-title":"J Nanobiotechnology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e145","article-title":"Comparison of newly proposed LDL-cholesterol estimation equations","volume":"38","author":"Jeong YW","year":"2023","unstructured":"Jeong YW, Koo JH, Huh JH, Kim YJ, Jeong H, Kim EY, Kang DR. Comparison of newly proposed LDL-cholesterol estimation equations. J Korean Med Sci. 2023, 38:e145. 10.3346\/jkms.2023.38.e145","journal-title":"J Korean Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8180424","article-title":"Lipoproteins as markers for monitoring cancer progression","volume":"2021","author":"Maran L","year":"2021","unstructured":"Maran L, Hamid A, Hamid SBS. Lipoproteins as markers for monitoring cancer progression. J Lipids. 2021, 2021:8180424. 10.1155\/2021\/8180424","journal-title":"J Lipids"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13851","article-title":"Metabolic biomarkers in lung cancer screening and early diagnosis (review)","volume":"25","author":"Xu Y","year":"2023","unstructured":"Xu Y, Dong X, Qin C, et al.. Metabolic biomarkers in lung cancer screening and early diagnosis (review). Oncol Lett. 2023, 25:265. 10.3892\/ol.2023.13851","journal-title":"Oncol Lett"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.05.004","article-title":"Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies","volume":"11","author":"Lin X","year":"2017","unstructured":"Lin X, Lu L, Liu L, Wei S, He Y, Chang J, Lian X. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. J Clin Lipidol. 2017, 11:1073-81. 10.1016\/j.jacl.2017.05.004","journal-title":"J Clin Lipidol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20194027","article-title":"A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy","volume":"40","author":"Hu C","year":"2020","unstructured":"Hu C, Liu Z, Zhao H, Wu L, Lian Q, Ma D, Li JV. A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy. Biosci Rep. 2020, 40:BSR20194027. 10.1042\/BSR20194027","journal-title":"Biosci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31575-y","article-title":"Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression","volume":"13","author":"Hartmann P","year":"2023","unstructured":"Hartmann P, Trufa DI, Hohenberger K, et al.. Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression. Sci Rep. 2023, 13:5662. 10.1038\/s41598-023-31575-y","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/1735-3327.197036","article-title":"Analysis of lipid profile in cancer patients, smokers, and nonsmokers","volume":"13","author":"Reddy AV","year":"2016","unstructured":"Reddy AV, Killampalli LK, Prakash AR, Naag S, Sreenath G, Biraggari SK. Analysis of lipid profile in cancer patients, smokers, and nonsmokers. Dent Res J (Isfahan). 2016, 13:494-9. 10.4103\/1735-3327.197036","journal-title":"Dent Res J (Isfahan)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-750","article-title":"Molecular biomarkers in early stage lung cancer","volume":"10","author":"Rodr\u00edguez M","year":"2021","unstructured":"Rodr\u00edguez M, Ajona D, Seijo LM, et al.. Molecular biomarkers in early stage lung cancer. Transl Lung Cancer Res. 2021, 10:1165-85. 10.21037\/tlcr-20-750","journal-title":"Transl Lung Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323921-comparative-analysis-of-biochemical-and-lipid-profile-markers-at-different-stages-of-lung-cancer-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T14:06:29Z","timestamp":1734271589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323921-comparative-analysis-of-biochemical-and-lipid-profile-markers-at-different-stages-of-lung-cancer-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.75737","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,15]]}}}